Citation Tools

A RANDOMISED PHASE TWO STUDY OF CARBOPLATIN VERSUS CARBOPLATIN AND THALIDOMIDE IN PATIENTS WITH OVARIAN CANCER, WITH EVALUATION OF POTENTIAL SURROGATE MARKERS OF ANGIOGENESIS

Download to a citation manager

Cite this article as:
Muthuramalingam SR, Braybrooke JP, Madhusudan S, et al
A RANDOMISED PHASE TWO STUDY OF CARBOPLATIN VERSUS CARBOPLATIN AND THALIDOMIDE IN PATIENTS WITH OVARIAN CANCER, WITH EVALUATION OF POTENTIAL SURROGATE MARKERS OF ANGIOGENESIS